Home/Filings/4/0000950138-18-000669
4//SEC Filing

ARLOTTA JOHN 4

Accession 0000950138-18-000669

CIK 0001532063other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 4:15 PM ET

Size

5.3 KB

Accession

0000950138-18-000669

Insider Transaction Report

Form 4
Period: 2018-12-20
ARLOTTA JOHN
CEO, eviCore healthcare
Transactions
  • Disposition to Issuer

    Common Stock

    2018-12-206,6880 total
Footnotes (1)
  • [F1]Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the "Merger"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a unit with respect to common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.

Issuer

Express Scripts Holding Co.

CIK 0001532063

Entity typeother

Related Parties

1
  • filerCIK 0001266153

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:15 PM ET
Size
5.3 KB